论文部分内容阅读
一种新的大环内酯化合物,结构如图,是从链霉菌Streptomyces sp.A-7361培养液中得到的,有抑制胆固醇生物合成的活性,可用于治疗动脉硬化。
A novel macrolide compound, shown in Fig., Is obtained from the Streptomyces sp. A-7361 culture and inhibits cholesterol biosynthesis and can be used to treat arteriosclerosis.